EUVIMEDEUVIMED entdecken
Crossref

Insulin-mediated GLUT4 translocation via small molecule binding of UNC119B for the treatment of diabetes mellitus

Autumn E. Moore

Iowa Research Online (The University of Iowa) · 24.04.2023

DOI: 10.25820/etd.007291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iowa Research Online (The University of Iowa), erschienen am 24.04.2023. Verfasst von Autumn E. Moore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type II diabetes (T2D) is a disease that is characterized by insulin resistance, hyperglycemia, and impaired insulin secretion via pancreatic b-cells. In skeletal muscle and adipose cells, T2D results in the dysregulation of downstream functions associated with the insulin signaling pathways. In this disease state, insulin is unable to bind receptors that trigger a signaling cascade that triggers GLUT4 in the vesicles to translocate to the surface of cells for glucose storage. Impaired GLUT4 translocation results in the accumulation of glucose in blood, resulting in hyperglycemia. Currently, treatments for diabetes have largely failed to control blood glucose levels through utilization of endogenous insulin or correct insulin insensitivity. As a result, a luciferase-based assay was developed to identify small molecules that could restore GLUT4 translocation in the presence of endogenous insulin in order to prevent hypoglycemia. In identifying small molecule mediators of insulin-dependent GLUT4 translocation, the X-ray crystal structure of small molecule insulin sensitizer bound to UNC119B was utilized to guide the design and synthesis of novel small molecule insulin sensitizers. Concurrently, multiple different structures that were predicted to bind UNC119B were evaluated in silico and identified synthetically tractable compounds from computational and docking analyses. Compounds C59 and 237 were amongst the most potent and efficacious agents that increased insulin-mediated GLUT4 translocation through binding of UNC119B. Issues arose in solubilizing the compounds in water due to both being comprised of aromatic and adamantyl moieties. To remedy this issue, phase solubility studies were conducted to identify the most compatible cyclodextrin to complex with C59 and 237. Of the 3 cyclodextrins tested (alpha, gamma, and hydroxypropyl-beta), hydroxypropyl-beta-cyclodextrin increased both C59 and 237 water solubility from 1 mM and >4 mM, respectively.

Schlagwörter

type 2 diabetesinsulin resistanceGLUT4 translocationinsulin signalingX-ray crystal structurecomputer-aided drug designmolecular dockingphase solubilityhydroxypropyl-β-cyclodextrinaqueous solubility enhancement

Zitieren

APA

Moore, A. E. (2023). Insulin-mediated GLUT4 translocation via small molecule binding of UNC119B for the treatment of diabetes mellitus. Iowa Research Online (The University of Iowa). https://doi.org/10.25820/etd.007291

Vancouver

Moore AE. Insulin-mediated GLUT4 translocation via small molecule binding of UNC119B for the treatment of diabetes mellitus. Iowa Research Online (The University of Iowa). 2023. doi:10.25820/etd.007291

BibTeX
@article{Moore2023,
  author = {Moore, Autumn E.},
  title = {Insulin-mediated GLUT4 translocation via small molecule binding of UNC119B for the treatment of diabetes mellitus},
  journal = {Iowa Research Online (The University of Iowa)},
  year = {2023},
  doi = {10.25820/etd.007291}
}
Kostenlos starten →